BRCA2 and melanoma: A highly significant overlap of transcript expression in melanoma cell lines after cisplatin treatment with transcripts involved in DNA repair and DNA damage response genes BRCA1, BRCA2, ATM and CHEK2 was observed, which may be compensating for diminished NER capacity.